Latin America Metabolic Testing Market By Technology (REE, Body Composition Analysis)
According to the Latin America Metabolic Testing Market Forecast Report, the market worth USD 20 million in 2016 and estimated to grow at a CAGR of 7%, to reach USD 27 million by 2021.
(EMAILWIRE.COM, June 19, 2018 ) Practice parameters for global developmental delay (GDD) and intellectual disability (ID) have not endorsed complete metabolic evaluations due to the low diagnostic yield. Intellectual disability and GDD are not unusual and overlapping disorders that impact the patient, family, and society. The predicted prevalence of ID in evolved nations is 3 to 4% but varies among different research from 1 to 10%. One study showed that ID turned into the ailment class with the largest health care expenses, nearly equal to the monetary effect of stroke, heart sickness, and most cancers mixed Establishing an accurate diagnosis for ID/GDD patients is essential for proper medical management, for genetic counseling and anticipatory guidance, and for the prevention of unnecessary and costly additional testing. A diagnosis will also allow the patient to access research protocols, and provide better state and federal funding for therapeutic and social services.
Until now, there was a lack of consensus concerning the precise medical and laboratory evaluations for these patients. The elevated newborn display screen with tandem mass spectrometry is one of the principal advances in screening for potentially treatable illnesses. Nevertheless, the number of tested disorders still varies state by state within the United States, as well as in Europe, and ranges anywhere from 2 to 54. In 2006, the American College of Medical Genetics (ACMG) suggested to screen for 29 core conditions and 25 diseases as secondary targets, 10 a recommendation that will hopefully be more widely adopted.
Study addresses the yield of targeted metabolic research throughout an evaluation at tertiary care in children with ID after a previous broad-based evaluation. Of their cohort, they locate an underlying motive for ID in 14% (59/433 patients) of patients. Among them, 5.1% (22/433) have been recognized with a genetic cause (non-metabolic), 5.8% (25/433) with exogenic reasons, and 2.8% (12/433) with a metabolic sickness, of which almost 50% were potentially treatable.
Earlier than referral, almost all patients (87%) had passed through an extensive metabolic screening, conforming to Dutch guidelines for patients with DD/ID. The volume of the prereferral assessment is probably accountable for the notably low diagnostic yield (14%) because different research that started with unscreened ID/GDD patients suggested yields ranging from 42.6 to 63%, for assessment, it might additionally have been useful if facts on the wide variety of patients diagnosed with this preliminary complete metabolic screen.
View sample and decide: https://www.marketdataforecast.com/market-reports/latin-america-metabolic-testing-market-4382/request-sample
Key trends and restrains
Metabolic testing hardware are utilized to evaluate the wellbeing and health of a person. These testing hardware are screening apparatuses to test organ execution in infection conditions, for example, diabetes and hypertension. There are a few strategies for Metabolic testing. VO2 max investigations, body organization examination, resting metabolic rate (RMR) investigation are one of them. A VO2 max test measures body's most extreme capacity to expend oxygen, which is connected to the physical wellness of that individual. Body structure examination is a physical test to quantify different segments, for example, protein, water substance, minerals, and fat in the body and their extents. It is utilized as a part of healing facilities, research facilities, rec centers, and games preparing focuses, to test and look at metabolic clutters, way of life infections, and dysmetabolic disorder X in the body.
To know more read: https://www.marketdataforecast.com/market-reports/latin-america-metabolic-testing-market-4382/
Demographically
Latin America is geographically segmented into Brazil, Argentina, Chile, Mexico and others. The overall market is to witness a growth of CAGR of 7% and a forecasted market value of USD 27 million by 2021.
Latin America Metabolic Testing Market Leaders are, Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).
The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Until now, there was a lack of consensus concerning the precise medical and laboratory evaluations for these patients. The elevated newborn display screen with tandem mass spectrometry is one of the principal advances in screening for potentially treatable illnesses. Nevertheless, the number of tested disorders still varies state by state within the United States, as well as in Europe, and ranges anywhere from 2 to 54. In 2006, the American College of Medical Genetics (ACMG) suggested to screen for 29 core conditions and 25 diseases as secondary targets, 10 a recommendation that will hopefully be more widely adopted.
Study addresses the yield of targeted metabolic research throughout an evaluation at tertiary care in children with ID after a previous broad-based evaluation. Of their cohort, they locate an underlying motive for ID in 14% (59/433 patients) of patients. Among them, 5.1% (22/433) have been recognized with a genetic cause (non-metabolic), 5.8% (25/433) with exogenic reasons, and 2.8% (12/433) with a metabolic sickness, of which almost 50% were potentially treatable.
Earlier than referral, almost all patients (87%) had passed through an extensive metabolic screening, conforming to Dutch guidelines for patients with DD/ID. The volume of the prereferral assessment is probably accountable for the notably low diagnostic yield (14%) because different research that started with unscreened ID/GDD patients suggested yields ranging from 42.6 to 63%, for assessment, it might additionally have been useful if facts on the wide variety of patients diagnosed with this preliminary complete metabolic screen.
View sample and decide: https://www.marketdataforecast.com/market-reports/latin-america-metabolic-testing-market-4382/request-sample
Key trends and restrains
Metabolic testing hardware are utilized to evaluate the wellbeing and health of a person. These testing hardware are screening apparatuses to test organ execution in infection conditions, for example, diabetes and hypertension. There are a few strategies for Metabolic testing. VO2 max investigations, body organization examination, resting metabolic rate (RMR) investigation are one of them. A VO2 max test measures body's most extreme capacity to expend oxygen, which is connected to the physical wellness of that individual. Body structure examination is a physical test to quantify different segments, for example, protein, water substance, minerals, and fat in the body and their extents. It is utilized as a part of healing facilities, research facilities, rec centers, and games preparing focuses, to test and look at metabolic clutters, way of life infections, and dysmetabolic disorder X in the body.
To know more read: https://www.marketdataforecast.com/market-reports/latin-america-metabolic-testing-market-4382/
Demographically
Latin America is geographically segmented into Brazil, Argentina, Chile, Mexico and others. The overall market is to witness a growth of CAGR of 7% and a forecasted market value of USD 27 million by 2021.
Latin America Metabolic Testing Market Leaders are, Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).
The scope of the report provides:
The evaluation of the current market for your product or services and the future implications of the market
Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future
Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment
Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share
The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porter’s Five Forces
The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors
Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments
Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence
Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
About MarketDataForecast™-
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results